Venera Kuci Emruli

Senaste forskningsoutput

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou, N. , Ntoufa, S. , Tsagiopoulou, M. , Moysiadis, T. , Bhoi, S. , Malousi, A. , Psomopoulos, F. , Mansouri, L. , Laidou, S. , Papazoglou, D. , Gounari, M. , Pasentsis, K. , Plevova, K. , Kuci-Emruli, V. , Duran-Ferrer, M. , Davis, Z. , Ek, S. , Rossi, D. , Gaidano, G. , Ritgen, M. & 11 andra Oscier, D., Stavroyianni, N., Pospisilova, S., Davi, F., Ghia, P., Hadzidimitriou, A., Belessi, C., Martin-Subero, J. I., Pott, C., Rosenquist, R. & Stamatopoulos, K., 2019, I : International Journal of Cancer.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

A. Ljungars, Mårtensson, L., Jenny Mattsson, Kovacek, M., Sundberg, A., Tornberg, U-C., B. Jansson, Persson, N., V. Kuci Emruli, S. Ek, M. Jerkeman, M. Hansson, G. Juliusson, M. Ohlin, Frendéus, B., Teige, I. & Mattsson, M., 2018 dec 1, I : JCO Precision Oncology. 2, 1

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

Freiburghaus, C., Venera Kuci Emruli, Johansson, A., Eskelund, C. W., Grønbæk, K., Roger Olsson, Fredrik Ek, Mats Jerkeman & Sara Ek, 2018 apr 25, I : BMC Cancer. 18, 1, 466

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

Visa alla (9)

Senaste forskningsoutput

Venera Kuci Emruli

Affilieringar